Genomics

Dataset Information

Constitutively activating MEK1 mutations drive treatment refractory histiocytic neoplasms but confer response to ERK inhibition


ABSTRACT: Constitutively activating MEK1 mutations drive treatment refractory histiocytic neoplasms but confer response to ERK inhibition

PROVIDER: PRJNA1117906 | ENA |

REPOSITORIES: ENA